HK inno N

195940 · KOSDAQ · Health Care · SMALL CAP

Provisional Q4 2025 results.

HK inno N filed provisional (unaudited) separate results for Q4 2025: revenue of US$200M (+23.8% year on year), operating profit of US$27.5M (+64.5% year on year) and net income of US$19M (+44.3% year on year).

Earnings(Operating results (preliminary) (fair disclosure))· FILED 2026-02-10· RCEPT 20260210900522

US$200MRevenue
+23.8%Revenue vs a year earlier
US$27.5MOperating profit

Converted at 1 USD ≈ ₩1,458.54 (filing-date rate, 2026-02-10 close)

What happened

HK inno N filed provisional (unaudited) separate results for Q4 2025: revenue of US$200M (+23.8% year on year), operating profit of US$27.5M (+64.5% year on year) and net income of US$19M (+44.3% year on year).

These are preliminary figures the company disclosed ahead of its audited report; the final numbers can differ.

RevenueUS$200M
Revenue vs a year earlier+23.8%
Operating profitUS$27.5M
Net incomeUS$19M
PeriodQ4 2025 (separate)
Filed2026-02-10, Operating results (preliminary) (fair disclosure)
SourceDART rcept 20260210900522 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-02-10 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.